Quarterly report pursuant to Section 13 or 15(d)

Restatement of Previously Issued Financial Statements (Tables)

v3.22.2.2
Restatement of Previously Issued Financial Statements (Tables)
6 Months Ended
Jun. 30, 2022
Restatement of Previously Issued Financial Statements  
Summary of the effects of the restatement on each financial statement line item affected by the restatement as of the dates, and for the periods

The following tables summarize the restatement adjustments on each financial statement line item affected by the restatement as of the dates, and for the periods, indicated:

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

    

As Previously

    

Network

    

Preferred Returns

    

Class A Units

    

Revenue

    

​

​

​

    

Reported

    

Adjustments

    

Adjustments

    

Adjustments

    

Adjustment

    

As Restated

Condensed Consolidated Statement of Operations for the Six Months Ended June 30, 2021 (Unaudited)

 

​

  

 

​

  

 

​

  

 

​

  

 

​

  

 

​

  

Capitated Revenue

​

$

294,860,130

​

$

—

​

$

—

​

$

—

​

$

(4,335,073)

​

$

290,525,057

Other Patient Service Revenue

​

 

8,122,849

​

 

—

​

 

—

​

 

—

​

 

(2,763,520)

​

 

5,359,329

Total Operating Revenue

​

 

302,982,979

​

 

—

​

 

—

​

 

—

​

 

(7,098,593)

​

 

295,884,386

Medical Expenses

​

 

297,570,662

​

 

—

​

 

—

​

 

—

​

 

(565,640)

​

 

297,005,022

Total Operating Expenses

​

 

335,409,517

​

 

—

​

 

—

​

 

—

​

 

(565,640)

​

 

334,843,877

Operating Loss

​

 

(32,426,538)

​

 

—

​

 

—

​

 

—

​

 

(6,532,953)

​

 

(38,959,491)

Interest Expense, net

​

 

(8,487,374)

​

 

—

​

 

3,993,325

​

 

—

​

 

—

​

 

(4,494,049)

Total Other Expenses

​

 

(19,148,953)

​

 

—

​

 

3,993,325

​

 

—

​

 

—

​

 

(15,155,628)

Net Loss Attributable to Non-Controlling Interests

​

 

(5,241,713)

​

 

5,241,713

​

 

—

​

 

—

​

 

—

​

 

—

Net Loss (formerly Net Loss Attributable to Controlling Interests)

​

 

(46,333,778)

​

 

(5,241,713)

​

 

3,993,325

​

 

—

​

 

(6,532,953)

​

 

(54,115,119)

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Condensed Consolidated Statement of Operations for the Three Months Ended June 30, 2021 (Unaudited)

​

 

  

​

 

  

​

 

  

​

 

  

​

 

  

​

 

  

Capitated Revenue

​

$

147,159,665

​

$

—

​

$

—

​

$

—

​

$

(5,598,799)

​

$

141,560,866

Other Patient Service Revenue

​

 

4,258,933

​

 

—

​

 

—

​

 

—

​

 

(1,233,356)

​

 

3,025,577

Total Operating Revenue

​

 

151,418,598

​

 

—

​

 

—

​

 

—

​

 

(6,832,155)

​

 

144,586,443

Medical Expenses

​

 

150,679,717

​

 

—

​

 

—

​

 

—

​

 

(299,200)

​

 

150,380,517

Total Operating Expenses

​

 

170,856,707

​

 

—

​

 

—

​

 

—

​

 

(299,200)

​

 

170,557,507

Operating Loss

​

 

(19,438,108)

​

 

—

​

 

—

​

 

—

​

 

(6,532,955)

​

 

(25,971,063)

Interest Expense, net

​

 

(4,406,240)

​

 

—

​

 

2,036,476

​

 

—

​

 

—

​

 

(2,369,764)

Total Other Expenses

​

 

(5,529,823)

​

 

—

​

 

2,036,476

​

 

—

​

 

—

​

 

(3,493,347)

Net Loss Attributable to Non-Controlling Interests

​

 

(1,959,421)

​

 

1,959,421

​

 

—

​

 

—

​

 

—

​

 

—

Net Loss (formerly Net Loss Attributable to Controlling Interests)

​

 

(23,008,510)

​

 

(1,959,421)

​

 

2,036,476

​

 

—

​

 

(6,532,955)

​

 

(29,464,410)

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Condensed Consolidated Statement of Changes in Members' Deficit for the Six Months Ended June 30, 2021

​

 

  

​

 

  

​

 

  

​

 

  

​

 

  

​

 

  

Preferred Return at 8% for Class A Units

​

$

1,817,564

​

$

—

​

$

(1,817,564)

​

$

—

​

$

—

​

$

—

Net Loss

​

 

(51,575,491)

​

 

—

​

 

3,993,325

​

 

—

​

 

(6,532,953)

​

 

(54,115,119)

Balance as of June 30,2021

​

 

(146,395,455)

​

 

—

​

 

6,743,106

​

 

(43,656,170)

​

 

—

​

 

(183,308,519)

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Condensed Consolidated Statement of Changes in Members' Deficit for the Three Months Ended June 30, 2021

​

 

  

​

 

  

​

 

  

​

 

  

​

 

  

​

 

  

Preferred Return at 8% for Class A Units

​

$

926,852

​

$

—

​

$

(926,852)

​

$

—

​

$

—

​

$

—

Net Loss

​

 

(24,967,931)

​

 

—

​

 

2,036,476

​

 

—

​

 

(6,532,955)

​

 

(29,464,410)

Balance as of June 30,2021

​

 

(146,395,455)

​

 

—

​

 

6,743,106

​

 

(43,656,170)

​

 

—

​

 

(183,308,519)

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Condensed Consolidated Statement of Cash Flows for the Six Months Ended June 30, 2021

​

 

  

​

 

  

​

 

  

​

 

  

​

 

  

​

 

  

Net Loss

​

$

(51,575,491)

​

$

—

​

$

3,993,325

​

$

​

​

$

(6,532,953)

​

$

(54,115,119)

Health Plan Settlements Receivable/Premiums Receivable

​

 

(5,320,861)

​

 

​

​

 

​

​

 

​

​

 

6,532,953

​

 

1,212,092

Class A and Class D Preferred Returns

​

 

3,993,325

​

 

—

​

 

(3,993,325)

​

 

​

​

 

—

​

 

—

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Condensed Consolidated Statements of Changes in Members' Deficit for the 3 Months Ended March 31, 2021

​

 

  

​

 

  

​

 

  

​

 

  

​

 

  

​

 

  

Preferred Return at 8% for Class A Units

​

$

890,612

​

$

​

​

$

(890,612)

​

$

—

​

$

—

​

$

—

Net Loss

​

 

(26,607,560)

​

 

​

​

 

1,956,848

​

 

—

​

 

—

​

 

(24,650,712)

Balance as of March 31,2021

​

 

(122,918,168)

​

 

​

​

 

5,633,581

​

 

(43,656,269)

​

 

6,532,954

​

 

(154,407,902)

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Consolidated Statements of Changes in Members' Deficit for the Year Ended December 31, 2020

​

 

  

​

 

  

​

 

  

​

 

  

​

 

  

​

 

  

Balance as of December 31, 2020

​

$

(97,661,735)

​

$

—

​

$

4,567,346

​

$

(43,656,270)

​

$

6,532,954

​

$

(130,217,705)

*Rounding may cause variances